HF
EW icon

HRT Financial’s Edwards Lifesciences EW Stock Holding History

HRT Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,800
Closed -$409K – 4059
2025
Q4 		$409K Buy
+4,800
New +$394K ﹤0.01% 2215

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HRT Financial's EW Position: Q1 2026 in Review

HRT Financial reduced its Edwards Lifesciences (EW) stake by 79% in Q1 2026, selling an estimated $10.8M and leaving 34,242 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #1391.

HRT Financial first reported a position in EW in Q2 2019 and has held it in 12 quarters since. The position peaked at $19.7M in Q2 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • HRT Financial held 34,242 shares of Edwards Lifesciences worth $2.74M as of Q1 2026.
  • HRT Financial sold 131,388 Edwards Lifesciences shares in Q1 2026, an estimated $10.8M.
  • Edwards Lifesciences made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1391 holding.
  • HRT Financial first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 12 quarters since.
  • HRT Financial's Edwards Lifesciences position peaked at $19.7M in Q2 2019.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.